Author: Khyati Shah

The Central Drugs Standard Control Organisation (CDSCO), India's National Regulatory Authority, has approved Gennova Biopharmaceuticals Limited's work on the country's first mRNA-based COVID-19 vaccine for its clinical data of the... Read More

India’s first domestically developed mRNA-based Covid-19 vaccine candidate has been found safe in its interim Phase 1 clinical trials, and the national drugs regulator has granted approval to its maker,... Read More

Emcure Pharmaceuticals Limited, one of India's biggest pharmaceutical businesses, has filed its Draft Red Hearing Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI) to raise funds... Read More

Emcure Pharmaceuticals Limited, pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas, has filed its Draft Red Hearing Prospectus... Read More

mcure Pharmaceuticals on Thursday said it has filed draft papers with Sebi for initial public offer (IPO). Sources said the size of the offer could be in the range of... Read More

Emcure Pharmaceuticals Limited, one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas, has filed... Read More

Emcure Pharmaceuticals Limited has filed its draft IPO (Initial Public Offering) papers with capital markets regulator SEBI. The company is looking to raise more than Rs 1,100 crore through the... Read More

Gennova Biopharmaceuticals on Tuesday received approval from the Drugs Controller General of India (DCGI) to start Phase II/III trials for its Covid-19 vaccine. Gennova has developed the HGCO19 Covid-19 vaccine,... Read More

Coronavirus update: India’s first mRNA-based Covid 19 vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for phase 2/3 clinical trials, the Department of Biotechnology (DBT) said on... Read More

Pune-based Emcure Pharmaceuticals Ltd. filed its draft red herring prospectus with the Securities and Exchanges Board of India on Thursday. The company is looking to raise Rs 1,100 crore through... Read More